This study indicates that the impaired mitochondrial function may be a barrier to tumorigenesis by activating p53 in oncocytomas, while subsequent alterations of p53 and other nuclear genes lead to malignant ChRCC. The gene discussed is TP53; the disease is oncocytic adenoma.